Katherine L. Neville, Ph.D.

For clients seeking patent protection in all areas of biotechnology and pharmaceuticals, Katherine L. Neville, Ph.D. delivers guidance to secure their inventions worldwide. She calls on her advanced studies in microbiology and immunology and near decade of patent prosecution experience to advance their business goals. In addition to counseling clients in strategic management of worldwide patent rights, her extensive experience includes patent preparation, opinions, due diligence analyses for clients interested in partnering, and various patent proceedings. Dr. Neville serves clients ranging from non-profit institutions to biotech startups to big pharma, and capably understands their diverse needs across a wide range of technologies. Recent Client Work: Successfully obtained patent protection for start-up enabling it to partner with Fortune 500 pharmaceutical company and move ahead with product. Patent covered a composition for directing compounds to the brain for treating a variety of CNS disorders. Reliably guided client through freedom to operate analysis and patent application processes in their development of new vaccine therapies for pandemic influenza viruses. Representative Experience Dr. Neville has skillfully worked on patent matters in diverse technologies, including: Genomics/Proteomics Antibody technology Growth factors Cell adhesion molecules Vaccine compositions Diagnostic and therapeutic methods Recombinant protein production Protein purification Transgenic animals Cell-based therapeutics Background and Credentials: Dr. Neville has extensively prosecuted domestic and foreign patents, provided due diligence analyses, handled interference, reexamination and opposition proceedings, as well as given non-infringement, patentability, freedom to operate and validity opinions. She received her J.D. cum laude from The John Marshall Law School. Prior to joining the firm, Dr. Neville earned her Ph.D. in 2001 from the Department of Microbiology and Immunology at Northwestern University Medical School. Her graduate work focused on experimental models of the autoimmune disease Multiple Sclerosis, specifically investigating potential therapeutic methods involved in the regulation of auto-reactive T cell function and their consequent effects on the progression of autoimmune disease. She received her B.S. in Biochemistry from the University of Notre Dame in 1995. Publications and Speeches: Dr. Neville has published several articles in peer-reviewed scientific journals and frequently presents CLE seminars on emerging topics in the biotech field, such as recent developments in case law as well as current trends at the US Patent and Trademark Office. Community and Professional Involvement: Intellectual Property Law Association of Chicago (IPLAC), Biotech Committee Member Association of University Technology Managers (AUTM), Member.